{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:51:42Z","timestamp":1761663102718},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jbspin.2012.06.023","type":"journal-article","created":{"date-parts":[[2012,9,19]],"date-time":"2012-09-19T18:31:12Z","timestamp":1348079472000},"page":"96-98","source":"Crossref","is-referenced-by-count":7,"title":["Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in ankylosing spondylitis"],"prefix":"10.1016","volume":"80","author":[{"given":"Gergely","family":"Toldi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bal\u00e1zs","family":"Szalay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Bek\u0151","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barna","family":"V\u00e1s\u00e1rhelyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attila","family":"Balog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2012.06.023_bib0005","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0268-9499(94)90717-X","article-title":"The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion","volume":"8","author":"Dan\u00f8","year":"1994","journal-title":"Fibrinolysis"},{"key":"10.1016\/j.jbspin.2012.06.023_bib0010","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1093\/clinchem\/43.10.1868","article-title":"ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients","volume":"43","author":"Stephens","year":"1997","journal-title":"Clin Chem"},{"key":"10.1016\/j.jbspin.2012.06.023_bib0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/00365540310017366","article-title":"Soluble urokinase receptor is elevated in cerebrospinal fluid from patients with purulent meningitis and is associated with fatal outcome","volume":"36","author":"Ostergaard","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jbspin.2012.06.023_bib0020","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1128\/CDLI.8.6.1196-1203.2001","article-title":"Expression of urokinase plasminogen activator receptor on monocytes from patients with relapsing-remitting multiple sclerosis: effect of glatiramer acetate (copolymer 1)","volume":"8","author":"Balabanov","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jbspin.2012.06.023_bib0025","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1515\/cclm.2011.656","article-title":"Soluble urokinase Plasminogen Activator Receptor (suPAR) levels in healthy pregnancy and preeclampsia","volume":"49","author":"Toldi","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jbspin.2012.06.023_bib0030","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2796.2010.02252.x","article-title":"Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population","volume":"268","author":"Eugen-Olsen","year":"2010","journal-title":"J Intern Med"},{"key":"10.1016\/j.jbspin.2012.06.023_bib0035","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/172460080101600402","article-title":"Soluble urokinase plasminogen activator receptor measurements: influence of sample handling","volume":"16","author":"Riisbro","year":"2001","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.jbspin.2012.06.023_bib0040","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","article-title":"Ankylosing spondylitis","volume":"9570","author":"Braun","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2012.06.023_bib0045","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2012.06.023_bib0050","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/jcp.46.3.198","article-title":"ICSH recommendations for measurement of erythrocyte sedimentation rate. International council for standardization in haematology (Expert panel on blood rheology)","volume":"46","author":"ICSH","year":"1993","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jbspin.2012.06.023_bib0055","doi-asserted-by":"crossref","first-page":"808724","DOI":"10.1155\/2012\/808724","article-title":"Adaptive immunity in ankylosing spondylitis: phenotype and functional alterations of T-cells before and during infliximab therapy","volume":"2012","author":"Szalay","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jbspin.2012.06.023_bib0060","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar3257","article-title":"Reduced immunomodulation potential of bone marrow-derived mesenchymal stem cells induced CCR4+CCR6+Th\/Treg cell subset imbalance in ankylosing spondylitis","volume":"1","author":"Wu","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2012.06.023_bib0065","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/01.SMJ.0000066946.56322.3C","article-title":"Relationship between some acute phase reactants and the Bath Ankylosing Spondylitis Disease Activity Index in patients with ankylosing spondylitis","volume":"97","author":"Yildirim","year":"2004","journal-title":"South Med J"},{"key":"10.1016\/j.jbspin.2012.06.023_bib0070","first-page":"980","article-title":"Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis","volume":"26","author":"Spoorenberg","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2012.06.023_bib0075","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.58.8.488","article-title":"Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis","volume":"58","author":"Slot","year":"1999","journal-title":"Ann Rheum Dis"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X12001753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X12001753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:39:38Z","timestamp":1594687178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X12001753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1297319X12001753"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2012.06.023","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}